ICON Revenue 2012-2026 | ICLR
ICON annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- ICON revenue for the quarter ending June 30, 2026 was $2.063B, a 1.2% increase year-over-year.
- ICON revenue for the twelve months ending June 30, 2026 was $8.294B, a 3.26% increase year-over-year.
- ICON annual revenue for 2025 was $8.251B, a 0.76% increase from 2024.
- ICON annual revenue for 2024 was $8.189B, a 0.85% increase from 2023.
- ICON annual revenue for 2023 was $8.12B, a 4.89% increase from 2022.
|
ICON Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $8,251 |
| 2024 | $8,189 |
| 2023 | $8,120 |
| 2022 | $7,741 |
| 2021 | $5,481 |
| 2020 | $2,797 |
| 2019 | $2,806 |
| 2018 | $2,596 |
| 2017 | $1,758 |
| 2016 | $1,666 |
| 2015 | $1,575 |
| 2014 | $1,503 |
| 2013 | $1,336 |
| 2012 | $1,115 |
| 2011 | $946 |
|
ICON Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-06-30 | $2,063 |
| 2026-03-31 | $2,034 |
| 2025-12-31 | $2,154 |
| 2025-09-30 | $2,043 |
| 2025-06-30 | $2,039 |
| 2025-03-31 | $2,015 |
| 2024-12-31 | $1,948 |
| 2024-09-30 | $2,030 |
| 2024-06-30 | $2,120 |
| 2024-03-31 | $2,090 |
| 2023-12-31 | $2,066 |
| 2023-09-30 | $2,055 |
| 2023-06-30 | $2,020 |
| 2023-03-31 | $1,979 |
| 2022-12-31 | $1,962 |
| 2022-09-30 | $1,942 |
| 2022-06-30 | $1,935 |
| 2022-03-31 | $1,902 |
| 2021-12-31 | $1,885 |
| 2021-09-30 | $1,866 |
| 2021-06-30 | $871 |
| 2021-03-31 | $858 |
| 2020-12-31 | $760 |
| 2020-09-30 | $702 |
| 2020-06-30 | $620 |
| 2020-03-31 | $715 |
| 2019-12-31 | $725 |
| 2019-09-30 | $710 |
| 2019-06-30 | $695 |
| 2019-03-31 | $675 |
| 2018-12-31 | $679 |
| 2018-09-30 | $655 |
| 2018-06-30 | $642 |
| 2018-03-31 | $620 |
| 2017-12-31 | $455 |
| 2017-09-30 | $440 |
| 2017-06-30 | $431 |
| 2017-03-31 | $432 |
| 2016-12-31 | $435 |
| 2016-09-30 | $420 |
| 2016-06-30 | $411 |
| 2016-03-31 | $401 |
| 2015-12-31 | $403 |
| 2015-09-30 | $395 |
| 2015-06-30 | $389 |
| 2015-03-31 | $388 |
| 2014-12-31 | $390 |
| 2014-09-30 | $388 |
| 2014-06-30 | $376 |
| 2014-03-31 | $350 |
| 2013-12-31 | $345 |
| 2013-09-30 | $340 |
| 2013-06-30 | $334 |
| 2013-03-31 | $419 |
| 2012-12-31 | $300 |
| 2012-09-30 | $286 |
| 2012-06-30 | $277 |
| 2012-03-31 | $343 |
| 2011-12-31 | $243 |
| 2011-09-30 | $241 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.935B | $8.251B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Revvity (RVTY) | United States | $14.338B | 24.02 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |